Intuitive Surgical, Inc. $ISRG Shares Acquired by Huntington National Bank

Huntington National Bank lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 308,063 shares of the medical equipment provider’s stock after purchasing an additional 1,577 shares during the quarter. Intuitive Surgical comprises 1.0% of Huntington National Bank’s portfolio, making the stock its 22nd largest position. Huntington National Bank owned approximately 0.09% of Intuitive Surgical worth $174,475,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. IPG Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $1,550,000. Arista Wealth Management LLC raised its position in shares of Intuitive Surgical by 38.6% during the 4th quarter. Arista Wealth Management LLC now owns 1,993 shares of the medical equipment provider’s stock worth $1,129,000 after purchasing an additional 555 shares during the period. Kingsview Wealth Management LLC raised its position in shares of Intuitive Surgical by 3.3% during the 4th quarter. Kingsview Wealth Management LLC now owns 4,396 shares of the medical equipment provider’s stock worth $2,490,000 after purchasing an additional 139 shares during the period. Texas Capital Bank Wealth Management Services Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $229,000. Finally, Waystone Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $321,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG opened at $418.55 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $414.30 and a 12 month high of $603.88. The stock has a market cap of $148.23 billion, a P/E ratio of 50.73, a P/E/G ratio of 3.49 and a beta of 1.51. The stock’s 50 day moving average price is $455.79 and its 200 day moving average price is $507.97.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period last year, the company posted $1.81 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research reports. Argus dropped their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Truist Financial lowered their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research report on Wednesday, April 15th. Robert W. Baird raised their target price on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Raymond James Financial lowered their target price on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Finally, Bank of America lowered their target price on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $576.71.

Insider Activity

In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the transaction, the executive vice president directly owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. The trade was a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 5,701 shares of company stock worth $2,783,807 in the last quarter. 0.60% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.